Generlac
NDC Package 60432-038-64
Package Information
Generlac is a medication used by mouth or rectally to treat or prevent complications of liver disease (hepatic encephalopathy). Marketed by Morton Grove Pharmaceuticals, Inc., this product is identified by NDC 60432-038 and is authorized under FDA application ANDA074603.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60432 - Morton Grove Pharmaceuticals, Inc.
- 60432-038 - Generlac
- 60432-038-64 - 1892 mL in 1 BOTTLE, PLASTIC
- 60432-038 - Generlac
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (60432-038). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60432-038-64 identifies a specific commercial package of 1892 ml in 1 bottle, plastic of Generlac, labeled by Morton Grove Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Morton Grove Pharmaceuticals, Inc. on October 31, 1996. The current certification is valid through October 31, 2022.
What are the primary indications for this medication?
This drug is used by mouth or rectally to treat or prevent complications of liver disease (hepatic encephalopathy). It does not cure the problem, but may help to improve mental status. Lactulose is a colonic acidifier that works by decreasing the amount of ammonia in the blood. It is a man-made sugar solution.
How is this Morton Grove Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60432003864. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 1892 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.